机译:可溶性CD93参与代谢失调,但不影响颈动脉内膜-中膜厚度
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden,Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden,Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
DipartimentD di Scienze Farmacologiche e Biomolecolari, Universita di Milano, Milan, Italy,Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy;
DipartimentD di Scienze Farmacologiche e Biomolecolari, Universita di Milano, Milan, Italy,Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy;
Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy;
Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland,Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland;
Department of Medicine, University Medical Center Groningen, Groningen, the Netherlands;
Assistance Publique-Hopitaux de Paris, Service Endocrinologie-Metabolisme, Groupe Hospitalier Pitie-Salpetriere, Unites de Prevention Cardiovasculaire, Paris, France;
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland;
Department of Clinical and Experimental Medicine, Internal Medicine, Angiology and Arteriosclerosis Diseases, University of Perugia, Perugia, Italy;
Bracco Medical Department, Milan, Italy;
Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden;
Centre for Cardiovascular Genetics, University College London, London, U.K.;
Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden,Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden;
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden,Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden;
Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;
机译:代谢综合征及其成分与颈动脉内膜中层厚度和颈动脉与股骨斑块面积之间的关联:一项人群研究
机译:超声心动图心外膜脂肪厚度与代谢综合征患者的颈动脉内膜中层厚度有关。
机译:肠系膜脂肪厚度是代谢综合征的独立决定因素,可确定颈动脉内膜-中膜厚度增加的受试者。
机译:中国人群颈动脉内膜中层厚度与舒张指数的关系
机译:颈动脉内膜介质厚度及其与入射心力衰竭的关系减少和保存的射血分数:atherosclersis的多民族研究(Mesa)
机译:可溶性CD93参与代谢失调但不影响颈动脉内膜-中膜厚度
机译:可溶性CD93参与代谢失调,但不影响颈动脉内膜-中膜厚度